1
Press Release
Astellas Launches Global Campaign in Collaboration with
CNN as Part of Global Corporate Brand Activity
- Sponsors Tomorrow’s Hero in February and March 2018. : Tomorrow’s
Hero showcases young innovators who are transforming the world for a
brighter future -
Tokyo, February 16, 2018 - Astellas Pharma Inc. (President and CEO: Yoshihiko
Hatanaka, “Astellas”) launched “CNN Tomorrow’s Hero” as a part of its global
corporate brand campaign which in collaboration with CNN. The new multiplatfrom
campaign has digital and TV content which will air on CNN International and CNN
Digital.
In the global corporate brand campaign, as an exclusive sponsor of “Tomorrow’s Hero”
which will be broadcasted on CNN International, Astellas will expand its brand
campaign with a TV commercial and digital activities on relevant websites and social
media platforms.
The new campaign titled “Tomorrow's Hero” is a series profiling young scientists,
inventors and enterpreneurs who are making remarkable and innovative contributions
towards improving our environment, our health, our communities and transforming the
world for a brighter future
The company’s global commercial introduces the new campaign slogan, "with
Meaningful Science," which demonstrates Astella’s patient-focused approach. The
commercial features a group of Astellas employees as a group of cellists playing
together in perfect harmony, symbolizing employees’ innovative collaboration. The
performers are joined by a crowd of spectators captivated by the music which reflect
Astellas' pursuit of creating meaningful value for patients.
Tomorrow’s Hero is a new TV segment and it will run on CNN International in News
Stream and Hala Gorani Tonight (total 12 episodes planned).
###
2
About Astellas
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people
around the world through the provision of innovative and reliable pharmaceutical products. We focus on
Urology, Oncology, Immunology, Nephrology and Neuroscience as prioritized therapeutic areas while
advancing new therapeutic areas and discovery research leveraging new technologies/modalities. We are
also creating new value by combining internal capabilities and external expertise in the medical/healthcare
business. Astellas is on the forefront of healthcare change to turn innovative science into value for patients.
For more information, please visit our website at www.astellas.com/en.
About CNN
CNN Worldwide is a portfolio of two dozen news and information services across cable, satellite, radio,
wireless devices and the Internet in more than 200 countries and territories worldwide. Domestically, CNN
reaches more individuals on television, the web and mobile devices than any other cable TV news
organization in the United States. Internationally, CNN is the most widely distributed news channel
reaching almost 354 million households around the world; and CNN Digital is the #1 online news
destination across all platforms, with more unique visitors and video starts than any other
competitor. Additionally, CNN Newsource is the world’s most extensively utilized news service partnering
with hundreds of local and international news organizations around the world. CNN is a division of Turner
Broadcasting System, Inc., a Time Warner Company.
Contacts for inquiries or additional information:
Astellas Pharma Inc.
Corporate Communications
TEL: +81-3-3244-3201 FAX: +81-3-5201-7473
For inquiries about CNN programs:
Bipasha Bhattacharya (CNN Communications)
Tel: +852-3128-3568
